Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.63 |
| ▸ | RAB9A | P51151 | 2/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | HTT | P42858 | 2/20 | 0.56 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.51 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17066377 | 0.87 | S1PR4 (0.60) | NPC1RAB9AKMT2AMEN1S1PR4 | |
| SCHEMBL8596386 | 0.84 | S1PR4 (0.58) | NPC1RAB9AKMT2AMEN1S1PR4 | |
| SCHEMBL27867259 | 0.83 | KMT2A (0.56) | NPC1RAB9AKMT2AMEN1S1PR4 | |
| SCHEMBL4555887 | 0.83 | NPC1 (0.59) | NPC1RAB9AKMT2AMEN1S1PR4 | |
| SCHEMBL8437 | 0.82 | HTT (0.55) | NPC1RAB9AKMT2AMEN1S1PR4 | |
| SCHEMBL3142475 | 0.82 | S1PR4 (0.63) | NPC1RAB9AKMT2AMEN1S1PR4 | |
| SCHEMBL6427203 | 0.80 | S1PR4 (0.60) | NPC1RAB9AKMT2AMEN1S1PR4 | |
| SCHEMBL12880437 | 0.80 | S1PR4 (0.56) | NPC1RAB9AKMT2AMEN1S1PR4 | |
| SCHEMBL28403783 | 0.79 | S1PR4 (0.53) | NPC1RAB9AKMT2AMEN1S1PR4 | |
| SCHEMBL8149292 | 0.79 | ALDH1A1 (0.53) | NPC1RAB9AKMT2AMEN1S1PR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5939568-A | Accelerated catalysis of olefinic epoxidations | THE SCRIPPS RESEARCH INSTITUTE (US) | 1999-08-17 | — | — | US | claimed |
| WO-1998033786-A9 | ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS | — | 1998-12-30 | — | — | WO | claimed |
| WO-1998033786-A1 | ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-08-06 | — | — | WO | claimed |
| US-11826435-B2 | Conduritol aziridine derivatives and uses thereof | UNIVERSITY OF SASKATCHEWAN (CA) | 2023-11-28 | — | — | US | disclosed |
| CN-116589399-A | Preparation method of 3-methoxy-2-nitropyridine | 济南大学 | 2023-08-15 | — | — | CN | disclosed |
| CN-107406494-B | Novel PD-L1 binding polypeptides for imaging | 百时美施贵宝公司 | 2022-03-25 | — | — | CN | disclosed |
| US-20190127397-A1 | Complexes for Nucleophilic, Radical, and Electrophilic Polyfluoroalkylation | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2019-05-02 | — | — | US | disclosed |
| US-20190127397-A1 | Complexes for Nucleophilic, Radical, and Electrophilic Polyfluoroalkylation | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2019-05-02 | — | — | US | disclosed |
| US-10113049-B2 | Thermoplastic resin composition | NIPPON NYUKAZAI CO., LTD. (JP) | 2018-10-30 | — | — | US | disclosed |
| EP-2940000-B1 | PROCESS FOR PREPARING METHYL ACETATE | DALIAN INST CHEMICAL PHYSICS CAS (CN) | 2017-10-18 | — | — | EP | disclosed |
| US-9440226-B2 | Method for preparing methyl acetate | DALIAN INSTITUTE OF CHEMICAL PHYSICS, CHINESE ACADEMY OF SCIENCES (CN) | 2016-09-13 | — | — | US | disclosed |
| EP-0897912-A1 | Amidino derivatives useful as nitric oxide synthase inhibitors | G.D. SEARLE & CO. (US) | 1999-02-24 | — | — | EP | disclosed |
| WO-1998033786-A9 | ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS | — | 1998-12-30 | — | — | WO | disclosed |
| US-5854234-A | Amidino dervatives useful as nitric oxide synthase inhibitors | G. D. SEARLE & CO. (US) | 1998-12-29 | — | — | US | disclosed |
| WO-1998033786-A1 | ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-08-06 | — | — | WO | disclosed |
| EP-0734386-A1 | PLATELET ACTIVATING FACTOR ANTAGONISTS: IMIDAZOPYRIDINE INDOLES | Abbott Laboratories (US) | 1996-10-02 | — | — | EP | disclosed |
| EP-0724570-A1 | AMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | G.D. SEARLE & CO. (US) | 1996-08-07 | — | — | EP | disclosed |
| US-5486525-A | ANTIINFLAMMATORY AGENTS | ABBOTT LABORATORIES (US) | 1996-01-23 | — | — | US | disclosed |
| WO-1995016687-A1 | PLATELET ACTIVATING FACTOR ANTAGONISTS: IMIDAZOPYRIDINE INDOLES | ABBOTT LABORATORIES (US) | 1995-06-22 | — | — | WO | disclosed |
| WO-1995011231-A1 | AMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | G. D. SEARLE & CO. (US) | 1995-04-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11826435-B2 | Conduritol aziridine derivatives and uses thereof | GAA, MAN2B1, GBA3 | NPC1 492/4885RAB9A 196/4885KMT2A 4103/4885 |
| US-20190127397-A1 | Complexes for Nucleophilic, Radical, and Electrophilic Polyfluoroalkylation | NBAS, PFAS, PCBP1 | NPC1 813/4885RAB9A 3414/4885KMT2A 2534/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.